Citadel Advisors
CLDX icon

Citadel Advisors’s Celldex Therapeutics CLDX Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$7.71M Sell
378,738
-224,663
-37% -$4.57M ﹤0.01% 1560
2025
Q1
$11M Sell
603,401
-104,685
-15% -$1.9M ﹤0.01% 1196
2024
Q4
$17.9M Sell
708,086
-139,195
-16% -$3.52M ﹤0.01% 988
2024
Q3
$28.8M Buy
847,281
+526,069
+164% +$17.9M 0.01% 701
2024
Q2
$11.9M Buy
321,212
+235,766
+276% +$8.73M ﹤0.01% 1122
2024
Q1
$3.59M Sell
85,446
-40,882
-32% -$1.72M ﹤0.01% 2023
2023
Q4
$5.01M Buy
126,328
+120,403
+2,032% +$4.78M ﹤0.01% 1648
2023
Q3
$163K Sell
5,925
-84,825
-93% -$2.33M ﹤0.01% 4637
2023
Q2
$3.08M Sell
90,750
-1,244,796
-93% -$42.2M ﹤0.01% 2075
2023
Q1
$48.1M Buy
1,335,546
+575,292
+76% +$20.7M 0.01% 464
2022
Q4
$33.9M Sell
760,254
-740,840
-49% -$33M 0.01% 618
2022
Q3
$42.2M Buy
1,501,094
+457,067
+44% +$12.8M 0.01% 469
2022
Q2
$28.1M Sell
1,044,027
-91,086
-8% -$2.46M 0.01% 638
2022
Q1
$38.7M Buy
1,135,113
+65,757
+6% +$2.24M 0.01% 546
2021
Q4
$41.3M Buy
1,069,356
+286,295
+37% +$11.1M 0.01% 562
2021
Q3
$42.3M Buy
783,061
+411,890
+111% +$22.2M 0.01% 527
2021
Q2
$12.4M Sell
371,171
-604,845
-62% -$20.2M ﹤0.01% 1278
2021
Q1
$20.1M Sell
976,016
-420,500
-30% -$8.66M ﹤0.01% 934
2020
Q4
$24.5M Buy
1,396,516
+1,371,367
+5,453% +$24M 0.01% 750
2020
Q3
$373K Sell
25,149
-34,359
-58% -$510K ﹤0.01% 3705
2020
Q2
$774K Buy
59,508
+34,997
+143% +$455K ﹤0.01% 3085
2020
Q1
$41K Buy
24,511
+8,772
+56% +$14.7K ﹤0.01% 4572
2019
Q4
$35K Buy
+15,739
New +$35K ﹤0.01% 4437
2019
Q3
Hold
0
4709
2019
Q2
Hold
0
4679
2019
Q1
Sell
-46,573
Closed -$9K 4572
2018
Q4
$9K Sell
46,573
-82,959
-64% -$16K ﹤0.01% 4413
2018
Q3
$59K Sell
129,532
-184,595
-59% -$84.1K ﹤0.01% 3987
2018
Q2
$159K Sell
314,127
-900,749
-74% -$456K ﹤0.01% 3746
2018
Q1
$2.83M Buy
1,214,876
+475,352
+64% +$1.11M ﹤0.01% 1688
2017
Q4
$2.1M Sell
739,524
-909,886
-55% -$2.58M ﹤0.01% 1873
2017
Q3
$4.72M Buy
1,649,410
+716,260
+77% +$2.05M ﹤0.01% 1298
2017
Q2
$2.3M Buy
933,150
+817,589
+707% +$2.02M ﹤0.01% 1616
2017
Q1
$417K Buy
115,561
+55,491
+92% +$200K ﹤0.01% 2711
2016
Q4
$213K Sell
60,070
-778,241
-93% -$2.76M ﹤0.01% 3030
2016
Q3
$3.39M Buy
838,311
+692,582
+475% +$2.8M ﹤0.01% 1268
2016
Q2
$640K Buy
145,729
+29,499
+25% +$130K ﹤0.01% 2079
2016
Q1
$439K Buy
116,230
+9,608
+9% +$36.3K ﹤0.01% 2294
2015
Q4
$1.67M Buy
106,622
+22,350
+27% +$350K ﹤0.01% 1671
2015
Q3
$889K Sell
84,272
-684,629
-89% -$7.22M ﹤0.01% 2233
2015
Q2
$19.4M Buy
768,901
+431,197
+128% +$10.9M 0.02% 712
2015
Q1
$9.41M Buy
337,704
+188,942
+127% +$5.27M 0.01% 1001
2014
Q4
$2.72M Sell
148,762
-14,880
-9% -$272K ﹤0.01% 1497
2014
Q3
$2.12M Buy
163,642
+82,881
+103% +$1.07M ﹤0.01% 1558
2014
Q2
$1.32M Buy
80,761
+3,181
+4% +$51.9K ﹤0.01% 1701
2014
Q1
$1.37M Sell
77,580
-33,689
-30% -$595K ﹤0.01% 1659
2013
Q4
$2.7M Sell
111,269
-234,943
-68% -$5.69M ﹤0.01% 1222
2013
Q3
$12.3M Buy
346,212
+264,711
+325% +$9.38M 0.02% 651
2013
Q2
$1.27M Buy
+81,501
New +$1.27M ﹤0.01% 1582